GE HealthCare Technologies Inc. Common Stock vs Plug Power Inc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.97 (market cap $31.07B), while Plug Power Inc trades at $1.41 (market cap $2.18B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 14.3× Plug Power Inc's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Plug Power Inc pays none. Which is the better fit depends on your goals.
| GEHC | PLUG | |
|---|---|---|
Market Cap | $31.07B | $2.18B |
Volume | 3,443,020 | 58,569,311 |
Sector | Health | Industrials |
52-Week High | $88.16 | $4.14 |
52-Week Low | $59.48 | $1.45 |
Enterprise Value | $39.53B | $3.05B |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 42 Days |
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Plug Power (PLUG) trades at $1.56, down 3.7% with a bearish technical outlook. The company shows persistent financial challenges with negative gross margins (-18.55%) and net income margin (-220.59%), though revenue grew to $710M in 2025. Recent news highlights strategic partnerships including a 280 MW electrolyzer agreement with Arcadia eFuels, positioning PLUG in the green hydrogen ecosystem. Cash flow remains negative with -$47M net cash flow in 2025, requiring ongoing financing.
Outlook remains speculative with significant execution risks despite analyst consensus of $2.65 price target (44.7% buy rating). The stock faces substantial operational losses, high cash burn, and competitive pressure in clean energy. Upside depends on successful hydrogen infrastructure deployment and margin improvement, while downside risks include funding challenges and delayed profitability.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets—including material handling, e-mobility, power generation, and industrial applications.
Read more on PLUG →